The four major Epstein-Barr virion envelope components were separated by column chromatography and reconstituted into artificial liposomes. These liposomes were tested for their ability to see reference 7) were performed by immunoprecipitation of virus-producing cells (16, 25, 26, 28, 31, 33) and virion particles (6). Despite molecular-weight discrepancies due to different polyacrylamide gel electrophoresis (PAGE) conditions and markers, a consistent pattern emerges.
Epstein-Barr (EB) virus causes infectious mononucleosis and is closely associated with two human malignant tumors, African Burkitt's lymphoma and undifferentiated nasopharyngeal carcinoma (for review see reference 7) . Two of these diseases are lymphoproliferative disorders of B-cell origin. Since virus receptors have been found only on B-lymphocytes of human and certain nonhuman primate origin, the surface components of EB virus play a major role in restricting the host range of the virus.
More recently, it has been shown that by artificially bypassing the membrane barrier EB virus genes are expressed in a wide range of naturally nonpermissive hosts (10, 35) , thus demonstrating the crucial role of the EB virus receptor in control of infection. Although the binding specificity of the EB virions has been demonstrated (20, 36) , very little is known about the molecular aspects. Other herpes-group viruses have been more extensively studied than EB virus, but little is known about the specific binding moieties of the virions (27, 30) .
Structural polypeptides of semipurified EB virions have been investigated (4, 5) . Comparison of the protein patterns of enveloped virions and Nonidet P-40-treated virions suggests that 10 of 34 structural proteins are envelope associated. The EB virus specificity of these proteins was not examined. Recent investigations concerning the EB membrane antigens (for review see reference 7) were performed by immunoprecipitation of virus-producing cells (16, 25, 26, 28, 31, 33) and virion particles (6) . Despite molecular-weight discrepancies due to different polyacrylamide gel electrophoresis (PAGE) conditions and markers, a consistent pattern emerges.
Four to five ,olypeptides ranging from 80 x 103 to 350 x 10 daltons comprise the membrane antigen complex on the cells. Membrane antigen components of similar size have been observed on the virion envelopes (6, 29) . Previously, we found that the virus envelope contains four major proteins and a fifth minor one which was neither labeled by surface labelings nor detected by immunoprecipitation of solubilized virions (unpublished data). To avoid confusion over molecular-weight sizing, we designated these protein moieties VE1 through VE5, in order of 'decreasing molecular weight. VE4 is the minor component. Furthermore, we were able to separate these components by molecular-weight column chromatography.
Utilizing the purified individual virion envelope proteins reconstituted in artificial liposomes, we have investigated the role of each as it pertains to virion binding to the EB virus receptor-positive cells. The two high-molecularweight components, VE1 and VE2, were found to be responsible for this property, both being needed for stable adherence of virus to cell. Neutralizing antisera which recognized these two components were also used in studies of this phenomenon. These tests revealed that the antisera directly inhibit virion binding to cells. This mode of action is responsible for virus neutral-ization in vitro and may be indicative of the in vivo immune response.
MATERIALS AND METHODS
Reagents and radolsotopes. Dextran T-10, Sepharose 6B, and Sephacryl S-300 were purchased from Pharmacia Chemicals, Sweden. Triton X-100, sodium dodecyl sulfate (SDS), phosphatidylcholine (lecithin), phosphatidylserine, and cholesterol were obtained from Sigma Chemical Co. L-[355]methionine (800 Ci/ mmol), [methyl-3H] thymidine (60 to 80 Cilmmol), and Nal2'I were purchased from New England Nuclear. '4C-methylated proteins, New England Nuclear products, were used as molecular-weight markers for SDS-PAGE: phosphorylase b (92,500), bovine serum albumin (69,000), ovalbumin (46,000), carbonic anhydrase (30,000), and cytochrome c (12,500). Unlabeled highmolecular-weight markers consisting of porcine thyroglobulin (669,000; subunit, 330,000), ferritin (440,000; subunit, 18,500), catalase (232,000; subunit, 60,000), lactate dehydrogenase (140,000; subunit, 36,000), and bovine serum albumin (67,000) were purchased from Pharmacia. Myosin (220,000) was a gift from J. Luka in our department.
Cells. Raji (8, 19) and Daudi (17, 19) are EB viruscarrying, receptor-positive, cell lines derived from Burkitt's lymphoma. YAC (18) , a mouse T-cell line, 1301 (9), a human T-cell line, and K562 (1, 37), a human erythroid-derived line, were used interchangeably as the EB virus receptor-negative control targets (35) . All cell culturing was performed in RPMI 1640 medium (GIBCO Laboratories, Scotland) supplemented with 10%o fetal calf serum and antibiotics (200 U of penicillin and 100 ,ug of streptomycin per ml) at 37°C, 5% C02, and 60%o humidity.
Virus purification and In vivo labeling. Virus-producing B95-8 cells were grown as suspension cultures for 1 week from an initial density of 3 x 105 cells per ml. The virus was metabolically labeled by adding
[3H]thymidine (2 FCi/ml) or ("Slmethionine (40 pCi/ ml) to the cell cultures on the first and fourth days. After the culture supernatants were harvested, the virus was purified by the procedure of Dolyniuk et al. (4) as modified previously by us (20.) Briefly, virus pelleted by centrifuging at 13,300 x g for 120 min was ultracentrifuged on successive 5 to 30%o and 10 to 30%o dextran gradients for 1 h each at 21,000 rpm in an SW 27.1 rotor (Beckman Instruments, Inc.). The dextran was dissolved in 0.5 mM phosphate buffer (pH 8.0) containing 1 mM EDTA and 0.02% NaN3 (gradient buffer). As demonstrated earlier (20) , the radioactivity and infectivity peaks of both gradients coincided at 17 to 18% dextran (Fig. IA, C, E) . The 17 to 18% dextran fractions of the first gradient were diluted twofold with gradient buffer before they were applied to the second gradient. The peak fractions of the second gradient were collected for use.
Virus was separated from dextran by column chromatography on Sepharose 6B in a column (0.7 by 30 cm) equilibrated with gradient buffer. Virion particles were collected in the void volume fractions and pelleted by centrifugation at 15,000 x g for 1 h. The pelleted virus was used for in vitro labeling and envelope solubilization.
Radiolodlnation of virlon -rtiles. The virus was iodinated with 1 mCi of Na1 I by one of two procedures, the chloramine-T method (24) or with lactoperoxidase-peroxide (23) . Approximately 100 FLg of dextran-free virus, determined by the method of Lowry et al. (22) , was suspended in 50 Il of phosphate-buffered saline (0.1 M phosphate buffer, pH 8.0, containing 0.15 M NaCl). In the chloramine-T method, the reaction was initiated by twice adding 10 jag of chloramine-T at a 1-min interval to the virus and Nal"I mixture. After a 2-min incubation, the reaction was quenched by introducing 20 ,ug of Na2S2Os dissolved in phosphate buffer containing 0.15 M Nal. Lactoperoxidase labeling was initiated by the addition of 10 ,ug of lactoperoxidase in phosphate-buffered saline and 10 Fl of 0.3% H202 to the virus and isotope mixture. The reaction was continued by adding 5 Fl of peroxide three times at 5-min intervals and was terminated by introducing 200 ,ul of phosphate buffer containing 0.15 M NaI. The labeled virus was separated from free iodine and chemicals by use of a Sepharose 6B column and was repurified on successive 5 to 30%o and 10 to 30%o dextran gradients, as above.
Detergent solubilization of virus. A sample of the dextran-free virus pellets was suspended (by gentle blending in a Vortex mixer) in 500 ,ul of 1% Triton X-100 in NET buffer (10 mM Tris-hydrochloride buffer, pH 8.0, containing 2 mM EDTA, 0.15 m NaCl, and 0.02% NaN3) and was incubated for 20 min at room temperature. The mixture was layered onto a 5 to 30%o dextran gradient containing 0.1% Triton X-100 and centrifuged at 21,000 rpm for 60 min in an SW 27.1 rotor. In the later studies, the Triton X-100-treated virus was centrifuged at 40,000 x g for 1 h to pellet the nucleocapsid.
Virion envelope component separation by column chromatography. Sephacryl S-300 packed in a column (1.2 by 90 cm) equilibrated and eluted with NET buffer containing 0.05% Nonidet P40 and 0.05% deoxycholate (Sigma); 0.5-ml fractions were collected. The column was calibrated with unlabeled and radioiodinated high-molecular-weight protein markers (Pharmacia).
Reconstitution of virion proteins in liposomes. Phosphatidylcholine, cholesterol, and phosphatidylserine, in the mass ratio of 7:2:1, were employed in the construction of artificial liposomes (2, 11, 15 Antisera. Origins, specificities, and references concerning the antisera used are listed in Table 1 . The EB virus-positive serum was a pool of two Burkitt's lymphoma and four nasopharyngeal carcinoma patients, all with high titers to EB virus-determined antigens (unpublished data). EB virus-negative serum was from a healthy, seronegative donor, devoid of detectable titers to EB virus antigens (unpublished data). The GJH sera were from the ascites fluids of a murine monoclonal, directed against VE1, and were the very kind gift of Gary J. Hoffman (14) . David Thorley-Lawson and Clark Edson kindly donated the DTL serum, a rabbit monospecific serum which recognizes both VE1 and VE2 (34) .
RESULTS
Specificity of radiolabeling and virion binding. We previously investigated the specificity and purity of the isotope labeling procedures on the virions (unpublished data). These results are summarized in Fig. 1 , 2, and 3. In short, the thymidine label was found to be associated with the virion nucleocapsid which appeared at 24 to 26% dextran after Triton treatment of the virion (Fig. 1B) , and the iodinated material was detected in the soluble proteins (Fig. 1F ). Proteins metabolically labeled by the addition of [35S]methionine were associated with both the nucleocapsid and soluble fractions (Fig. 1D) .
The thymidine-labeled material was examined by DNA extraction, restriction endonuclease treatment, and blot hybridization, and was found to be more than 95% pure, nondegraded EB virus DNA (A. Saemundsen, personal communication). lodinated and methionine-labeled components were precipitated with trichloroace- Table 2 .
The labeled virions were tested for their ability to adsorb specifically to receptor-positive cells ( Fig. 3) (20) . Ninety percent of the thymidine label was associated with virions which adsorbed to Raji cells. The percentages for methionine and iodinated virions were 70 and 40%, respectively. These levels are rough indicators of label purity, as discussed previously (20; unpublished data). In all labels the negative control cells bound less than 7% of the gross counts added.
Separation of envelope proteins by column chromatography. Solubilized, iodinated material was run in a Sephacryl S-300 column precalibrated with a series of nonlabeled and 1251_ labeled proteins (Fig. 4) . One-milliliter fractions were collected and counted, with the different peaks being pooled. These peak fractions were precipitated with trichloroacetic acid and analyzed by SDS-PAGE, with the autoradiograms being scanned by a scanning densitometer. The tracings revealed separation of the four major envelope proteins (Fig. 5) . VE4, which is poorly iodinated (unpublished data), was not detected. In later studies, we performed the iodination after solubilization of the virion and isolation of the envelope components. By this procedure we obtained a 10-fold greater labeling efficiency but (Fig.  6) . Both of the higher-molecular-weight envelope components demonstrated an inhibitory effect, whereas VE3 and VE5 did not. We investigated the time kinetics of the inhibition caused by VE2 (Fig. 7) because none of the individual envelope components presented stable binding (Fig. 8) . Nonlabeled VE2, [10] [11] [12] [13] Liposomes containing both VE1 and VE2 stably adsorb to EB virus receptor-positive cells. Individual iodinated virion proteins were incorporated into liposomes and assayed for ability to specifically bind to receptor-positive cells. As is shown in Fig. 8 , the liposomes containing individual virion envelope components did not display this property, whereas the liposomes containing both high-molecular-weight components did. Addition of 10 EB virus nucleocapsids were isolated from the 24 to 26% dextran fraction of Triton-treated, thymidine-labeled virions (Fig. 1B) and incorporated into liposomes along with nonlabeled envelope proteins. Because the label was protected from direct contact with the microenvironment, these liposomes could be employed to determine whether the liposomes are internalized by the cells. Liposomes containing the nucleocapsid and different combinations of the four major envelope components were adsorbed to receptor-positive and -negative cells for 2 h at 37°C, a temperature permissive for viral internalization (Fig. 10) . After this incubation, a sample of each liposome-cell mixture was trypsinized briefly to remove exposed surface structures. The trypsin treatment removed more than 80% of the specifically bound label in all cases. Because bare nucleocapsids demonstrate 30% of the binding level of virions (20) , a liposome containing only the nucleocapsid was reconstituted and tested in parallel (Fig. 10E) . This sample did not show any specific adsorption to EB virus receptor-positive cells, suggesting that the nucleocapsid was enveloped by the artificial liposomes.
Enzyme treatment of receptor site for virion components suggests identity with virion binding site. We have previously shown that the EB virus receptor is neuraminidase resistant but trypsin sensitive (20) . To demonstrate a correspondence between the liposome target structure and that of the virion as regards enzyme susceptibility, we treated Raji cells with neuraminidase or trypsin as described in the Fig. 11 legend. Adsorption by liposomes containing virion envelope components was not disturbed by neuraminidase, but pretreating the cells with trypsin eliminated specific binding, in agreement with the findings for the viable virions. The negative controls were also enzymatically treated to determine whether the high level of adsorption by liposomes containing virion envelope components observed after neuraminidase treatment is due to the generation of a "sticky surface." Such a situation is not observed with the negative cells. Additionally, a liposome containing all four envelope components was tested in parallel to assess the difference in binding between such a liposome and one containing only VE1 and VE2. No difference between the two was observed. The slight increase in liposome binding seen after the neuraminidase treatment is not significant, being within one standard error of the nontreated control. There are two possible sources of systematic error in our assays. These involve component purity and liposome composition. A number of precautions were instituted to control purity of the different envelope components. These proteins, though present in greater quantities on producer cells (6, 25, 28, 31, 33) , were isolated from three or four gradient-purified virions. The disadvantage of paucity of material was compensated by the low number of Triton-soluble proteins in these preparations, which yielded only four different soluble, iodinated components (Fig. 2) . These proteins were previously analyzed extensively by both trichloroacetic acid precipitation and immunoprecipitation (33; unpublished data). After column chromatography, narrow peaks were collected and purity was ascertained by trichloroacetic acid precipitation and SDS-PAGE (Fig. 5) . The samples were quite clean and free from significant cross-contamination. As a result of these controls, only trace amounts of proteins were obtainable. Approximately half of the protein added to the lipid mixture was pelleted with the reconstituted liposomes, as determined by distribution of label. However, with trace amounts of proteins involved, it was impossible to monitor the lipo- (Fig. 4) were collected and precipitated with trichloroacetic acid. The iodinated material was electrophoresed in a 5 to 15% gradient slab SDSpolyacrylamide gel under reducing conditions. The gel was dried and processed as described in the legend for Fig. 2 (20) .
In a number of preliminary experiments (data not shown), the binding moieties of viable virions were indirectly examined. Antisera which recognized a number of the four major envelope components were assayed for their effect on virus binding. After removal of immune complexes from the pooled human sera (12, 13) , the residual sera neutralized both infectivity and binding. Monospecific and monoclonal sera directed against either VE1 or VE2 also negated virion binding. As viral binding is the first step in infection, in vitro neutralization of virions by these sera is accomplished at this stage. Whether this mechanism is responsible for neutralization in vivo remains to be seen, though evidence has been presented suggesting that VE1 and VE2 are the major neutralizing targets in vivo (D. Thorley-Lawson, submitted for publication In summary, it has been shown that EB virus binding is mediated by only two of the virion envelope components, VE1 and VE2. For stable binding to occur, both components must be present. Previously, we reported an EB virus receptor which selectively binds only one of the two virus substrains, the P3HR-l-derived virus (36) . As the only demonstrated structural difference between the two viral substrains is the ratio of VE1 to VE2 (6; unpublished data), these findings are consistent with the idea that a complex of the two components is the basis for the virus' extreme target selectivity.
